SR9243, LXR Inverse Agonist

Overview
Catalog #	bs-60270c-2-mg-solid
Product Name	SR9243, LXR Inverse Agonist
Specifications
Storage Buffer	Powder
Storage Condition	Store in dry, dark place at -20C for 1 year.
Target
Product Information	Molecular Weight: 626.62 Formula: C31 H32 Br N O4 S2 CAS Number: 1613028-81-1 InChi Key: FYQFEJFTCLKXTQ-UHFFFAOYSA-N InChi: InChI=1S/C31H32BrNO4S2/c1-22-17-23(2)31(24(3)18-22)39(36,37)33(16-15-25-7-5-9-29(32)19-25)21-26-11-13-27(14-12-26)28-8-6-10-30(20-28)38(4,34)35/h5-14,17-20H,15-16,21H2,1-4H3 Smiles: CS(=O)(=O)C1C=C(C=CC=1)C1C=CC(CN(CCC2=CC(Br)=CC=C2)S(=O)(=O)C2C(C)=CC(C)=CC=2C)=CC=1 Purity: 98.0 Solubility: DMSO up to 50 mM Appearance: Solid Power. Shelf Life: 1.0 years
Description	SR9243 is a potent and selective LXR inverse agonist. SR9243 kills cancer cells by inhibiting lipid production and the Warburg effect. SR9243 induces cell death in multiple types of cancer and does not cause the side effects that have derailed previous attempts to target these processes. In cancer cells, SR9243 significantly inhibited the Warburg effect and lipogenesis by reducing glycolytic and lipogenic gene expression. SR9243 induced apoptosis in tumors without inducing weight loss, hepatotoxicity, or inflammation. Malignant cells exhibit aerobic glycolysis (the Warburg effect) and become dependent on de novo lipogenesis, which sustains rapid proliferation and resistance to cellular stress.